Demonstration Environment — Synthetic Patient Data. All patients, results, images, and AI outputs on this platform are fabricated for product demonstration and contain no real clinical information.

AI Specialist Council

Structured, evidence-grounded reasoning across all cases reviewed by the specialist agent council.

Elena Marsh
Cardiology · 4 months ago

Chest pain with rising troponin — evolving NSTEMI workup

Four specialist agents reviewed this case. Cardiology and Evidence & Guidelines agents concur that the biomarker and ECG pattern supports an early invasive strategy consistent with NSTE-ACS guidance. Pharmacology confirms current therapy is appropriate. Critical Care notes haemodynamics remain within tolerable range, creating a mild difference in urgency framing that the treating physician should reconcile with direct examination.

4 agents invoked
High confidence78%
Daniel Oyelaran
Neurology · 4 months ago

Acute stroke — thrombolysis and post-treatment monitoring

Neurology and Radiology agents concur that thrombolysis was appropriately administered within the eligible window based on imaging and clinical timeline. Pharmacology has abstained from recommending a precise anticoagulation resumption time, citing insufficient post-treatment imaging data. Critical Care flags a rising blood pressure trend approaching, but not yet exceeding, the post-thrombolysis management threshold.

4 agents invoked
Moderate confidence71%
Priya Natarajan
ICU · 4 months ago

Septic shock with early deterioration signals

Critical Care and Infectious Disease agents independently flag concerning trends — deteriorating haemodynamics and persistently rising CRP — that together suggest the current source-control and antimicrobial strategy may be insufficient. Nephrology and Pharmacology confirm renal dosing has been appropriately adjusted. This is a case with multimodal conflict between the expected treatment response and the observed clinical trajectory.

4 agents invoked
Moderate confidence68%
Walter Kucera
Nephrology · 4 months ago

AKI on CKD — medication-related contributor

All three invoked agents are in full agreement: the combination of self-directed NSAID use and background ACE-inhibitor therapy is the most probable contributor to this AKI episode, and current management (discontinuation of both agents, supportive care) is guideline-concordant. No disagreement identified in this case.

3 agents invoked
High confidence80%
Fatima Rasheed
Oncology · 4 months ago

New breast cancer diagnosis — staging and biomarker-directed planning

Radiology and Pathology agents show strong concordance confirming invasive ductal carcinoma with a BI-RADS 5 correlate. Oncology and Evidence & Guidelines agents agree the PIK3CA mutation supports consideration of targeted combination therapy pending multidisciplinary review. The BRCA2 variant remains of uncertain significance — the Pathology agent has explicitly abstained from asserting its relevance until germline testing is complete.

4 agents invoked
High confidence79%